文献速递淋巴瘤

液体活检:霍奇金淋巴瘤基因分型的非侵入性方法

Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping.
PubMed 文献 · Br J Haematol · 2021-07-27

该研究采用定制NGS panel联合独特分子标识符,对60例初诊霍奇金淋巴瘤患者的ctDNA进行基因分型。不良预后特征与ctDNA量显著升高相关。

要点

  • 常见变异基因包括SOCS1、IGLL5、TNFAIP3、GNA13、STAT6和B2M。
  • 高LDH、低白蛋白血症、B症状、IPI≥3或晚期与ctDNA量升高相关。

核心结论

  • 通过NGS检测ctDNA是描绘初诊霍奇金淋巴瘤患者遗传特征的可行方法。
  • 数据支持将液体活检基因分型用于霍奇金淋巴瘤患者的常规评估。

研究设计与样本

  • 采用定制NGS panel联合独特分子标识符,对60例初诊霍奇金淋巴瘤患者的ctDNA检测体细胞变异。
  • 49例样本ctDNA质量合格,纳入变异分析。

主要发现

  • 检出变异的基因及频率:SOCS1(28%)、IGLL5(26%)、TNFAIP3(23%)、GNA13(23%)、STAT6(21%)、B2M(19%)。
  • 高LDH、低血清白蛋白、B症状、IPI≥3或晚期等不良预后特征与显著更高的ctDNA量相关。

临床怎么用

  • 液体活检基因分型可作为霍奇金淋巴瘤初诊时非侵入性获取遗传信息的可行手段。
  • ctDNA检测结果需结合临床预后特征综合解读。

局限性

  • 研究仅纳入60例初诊患者,其中49例ctDNA质量合格可用于变异分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Hodgkin lymphoma (HL) genomic landscape is hardly known due to the scarcity of tumour cells in the tissue. Liquid biopsy employing circulating tumour DNA (ctDNA) can emerge as an alternative tool for non-invasive genotyping. By using a custom next generation sequencing (NGS) panel in combination with unique molecule identifiers, we aimed to identify somatic variants in the ctDNA of 60 HL at diagnosis. A total of 277 variants were detected in 36 of the 49 samples (73·5%) with a good quality ctDNA sample. The median number of variants detected per patient was five (range 1-23) with a median variant allele frequency of 4·2% (0·84-28%). Genotyping revealed somatic variants in the following genes: SOCS1 (28%), IGLL5 (26%), TNFAIP3 (23%), GNA13 (23%), STAT6 (21%) and B2M (19%). Moreover, several poor prognosis features (high LDH, low serum albumin, B-symptoms, IPI ≥ 3 or at an advanced stage) were related to significantly higher amounts of ctDNA. Variant detection in ctDNA by NGS is a feasible approach to depict the genetic features of HL patients at diagnosis. Our data favour the implementation of liquid biopsy genotyping for the routine evaluation of HL patients.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Alcoceba M, García-Álvarez M, Chillón MC, et al. Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. Br J Haematol. 2021. PMID: 34312841. doi:10.1111/bjh.17719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。